Growth-Hormone Secretion and Endocrine Studies

• CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analog studied in pre-clinical systems for its ability to stimulate growth hormone (GH) release from the pituitary via sustained GHRH-receptor activation. The DAC modification allows extended half-life and prolonged biological activity, enabling the study of chronic GH signaling and endocrine feedback.

Muscle-Regeneration and Recovery Models

• In animal studies, CJC-1295 with DAC has been observed to increase IGF-1 expression and myogenic signaling, supporting its use in research on skeletal-muscle growth, tissue regeneration, and post-exertion recovery.

Fat-Metabolism and Body-Composition Research

• Pre-clinical findings indicate CJC-1295 may enhance lipid oxidation and energy expenditure through GH-mediated metabolic pathways, providing a framework for examining body-composition and adipose-regulation mechanisms.

Pharmacokinetic and Half-Life Extension Studies

• The DAC modification (Drug Affinity Complex) covalently binds to serum albumin, significantly extending CJC-1295’s plasma half-life. This makes it a model compound for studying peptide stabilization, controlled-release pharmacology, and sustained GH modulation.

Collagen Production and Tissue-Repair Research

• Laboratory data suggest GH and IGF-1 upregulation by CJC-1295 can enhance fibroblast proliferation and collagen synthesis, offering value in tissue-healing and extracellular-matrix studies.

Bone and Joint-Health Models

• Experimental results in non-clinical systems have shown positive effects on bone remodeling, cartilage preservation, and mineral-density regulation, making CJC-1295 with DAC suitable for skeletal and connective-tissue research.

Sleep and Neuroendocrine Function Studies

• In pre-clinical investigations, GH-secretagogue compounds like CJC-1295 have been linked to enhanced sleep architecture and neuroendocrine signaling, aiding research into circadian rhythm, cognitive performance, and neural recovery.

Synergistic GH-Axis Research with GHRPs

• CJC-1295 with DAC is often co-studied with ghrelin mimetics such as GHRP-2, GHRP-6, and Ipamorelin to evaluate synergistic GH-release kinetics, feedback mechanisms, and combined endocrine responses.

STORAGE DETAILS

Lyophilized CJC-1295 DAC peptide is stable at room temperature for 90 days; however, it should NOT be stored below freezing for any extended period of time. After reconstituting, CJC-1295 DAC should be refrigerated at temperatures not to exceed 36°F.

Product Specifications

• Appearance: Solid, white powder in 3mL glass ampule

• Chemical Formula: C165H269N47O46

• PubChem CID: (Specify if available)

• CAS Number: 863288-34-0

• Molecular Weight: 3647.19 g/mol

• Synonyms: CJC-1295 with DAC, CJC-1295 DAC, 863288-34-0

• Storage: Store at ≤6°C, sealed, away from heat, light, and moisture.

• Concentration: ≥98%

  Research Use Only (RUO). Not for human or animal use. Not for diagnostic, therapeutic, or clinical applications. No claims are made regarding GH release, fat loss, or anti-aging effects in humans. End-user assumes responsibility for determining suitability for specific research protocols.